Cases started on MDR-TB treatment in South-East Asia (WHO region)
South-East Asia (WHO region): Cases started on MDR-TB treatment was 57,653 in 2024. ◆ Volatile
Latest (2024)
57,653
Change on year
down 11.8%
Rank
3rd
of 11 groups
All-time high
68,879
in 2019
All-time low
0
in 2005
Years of data
20
2005–2024
Cases started on MDR-TB treatment in South-East Asia (WHO region), 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
South-East Asia (WHO region) recorded 57,653 for cases started on mdr-tb treatment in 2024.
The figure is down 11.8% on the previous year and up 112.0% over ten years.
Over the whole period, cases started on mdr-tb treatment in South-East Asia (WHO region) peaked at 68,879 in 2019 and was at its lowest, 0, in 2005.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 0 | — |
| 2006 | 0 | — |
| 2007 | 0 | — |
| 2008 | 722 | — |
| 2009 | 2,020 | +179.8% |
| 2010 | 2,974 | +47.2% |
| 2011 | 4,331 | +45.6% |
| 2012 | 15,393 | +255.4% |
| 2013 | 23,287 | +51.3% |
| 2014 | 27,191 | +16.8% |
| 2015 | 31,129 | +14.5% |
| 2016 | 38,600 | +24.0% |
| 2017 | 42,635 | +10.5% |
| 2018 | 53,967 | +26.6% |
| 2019 | 68,879 | +27.6% |
| 2020 | 48,228 | -30.0% |
| 2021 | 58,202 | +20.7% |
| 2022 | 65,809 | +13.1% |
| 2023 | 65,381 | -0.7% |
| 2024 | 57,653 | -11.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 548.4 | 0 | 2,020 | 5 |
| 2010s | 30,839 | 2,974 | 68,879 | 10 |
| 2020s | 59,055 | 48,228 | 65,809 | 5 |
Countries ranked near South-East Asia (WHO region)
- 1 India 51,765 compare
- 2 Russian Federation 23,722 compare
- 3 China 13,984 compare
- 4 Indonesia 9,421 compare
- 5 Philippines 6,631 compare
- 6 South Africa 6,578 compare
More health data for South-East Asia (WHO region)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 17.14 % change on previous year (2025)
- Pertussis - number of reported cases 2,449 (2025)
- Diphtheria - number of reported cases 3,416 (2025)
- Measles - number of reported cases 19,075 (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in South-East Asia (WHO region)?
- Cases started on mdr-tb treatment in South-East Asia (WHO region) was 57,653 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in South-East Asia (WHO region)?
- The highest recorded value was 68,879 in 2019.
- What is the lowest cases started on mdr-tb treatment recorded in South-East Asia (WHO region)?
- The lowest recorded value was 0 in 2005.
- How does South-East Asia (WHO region) rank for cases started on mdr-tb treatment?
- South-East Asia (WHO region) ranks 3rd out of 11 groups with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 112.0%. The long-run trend across the full record is volatile.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).